Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors

Cai, 2020, Sex difference and smoking predisposition in patients with COVID-19, Lancet, 4, E20 Cheng, 2005, ABO blood group and susceptibility to severe acute respiratory syndrome, J. Am. Med. Assoc., 293, 1450 Dai, 2020, ABO blood group predisposes to COVID-19 severity and cardiovascular diseases, Eur. J. Prev Cardiol., 10.1177/2047487320922370 Ellinghaus, 2020, Severe covid-19 GWAS group. Genomewide association study of severe covid-19 with respiratory failure, N. Engl. J. Med. Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N. Engl. J. Med., 382, 1708, 10.1056/NEJMoa2002032 Guillon, 2008, Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies, Glycobiology, 18, 1085, 10.1093/glycob/cwn093 Jin, 2020, Gender differences in patients with COVID-19: focus on severity and mortality, Frontiers in Public Health, 8, 152, 10.3389/fpubh.2020.00152 Li, 2020, Early Transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia, N. Engl. J. Med., 382, 1199, 10.1056/NEJMoa2001316 Nurtop, 2018, Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies, Virol. J., 15, 192, 10.1186/s12985-018-1105-5 Slot, 2020 Zhang, 2020, Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China, Allergy, 2020 Zhao, 2020